Atlas Trials

Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl

Clinical trial NCT01074632 · COMPLETED

Trial details

NCT number
NCT01074632
Sponsor
Sumitomo Pharma America, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder
Start date
2009-05-01
Primary completion
2009-09-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.